JLABS | Thinking commercial during drug discovery and development
Thu 23 May | 14:30 – 18:00 CEST | Nijmegen & virtual
1 Min
More 
How the body switches out of “fight” mode - Study in Nature unlocks how cortisone inhibits inflammation
Cortisone and other related glucocorticoids are extremely effective at curbing excessive immune reactions. But previously, astonishingly little was known about how they exactly do that. A team of researchers from Charité – Universitätsmedizin Berlin…
4 Min
More Asahi Kasei Bioprocess and Axolabs announce strategic partnership to accelerate oligonucleotide therapeutics development
Düsseldorf, Tokyo and New York – April 11, 2024 – Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate…
2 Min
More ERC grants Berlin scientists €2.5 million each
Neuroscientists Gary Lewin and James Poulet at the Max Delbrück Center for Molecular Medicine have won highly coveted and competitive ERC Advanced Grants to study pain and the neural mechanisms that underlie temperature perception.
3 Min
More BIOTRONIK introduces new BIOMONITOR IV insertable cardiac monitor with artificial intelligence at EHRA congress 2024
BIOMONITOR IV and SmartECG Enable Workflow Optimization and Personalized Treatment Decisions
2 Min
More Charité Virology is a reference laboratory in the WHO Coronavirus Network CoViNet - Global network of reference laboratories aims to detect and monitor coronaviruses
The World Health Organization (WHO) has selected the Institute of Virology at Charité – Universitätsmedizin Berlin as a member of the newly established WHO Coronavirus Network (CoViNet). The global network of reference laboratories aims to detect and…
2 Min
More ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever
ProBioGen, a globally recognized and experienced Contract Development & Manufacturing Organization (CDMO), proudly announces a partnership with DIOSynVax Ltd to manufacture DIOS-HFVac3, a trivalent hemorrhagic fever (HF) vaccine that was developed in…
2 Min
More Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
Eckert & Ziegler BEBIG GmbH, subsidiary of Eckert & Ziegler SE with focus on brachytherapy solutions for the treatment of prostate cancer as well as eye and brain tumors, obtained the MDR certificate for its proprietary prostate seeds from DEKRA…
1 Min
More Bayer and Aignostics to collaborate on next generation precision oncology
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s precision oncology development portfolio
Co-development of a novel target…
2 Min
More Berlin-based HealthTech company Mika selected by White House Backed CancerX Accelerator Program
The app-based platform Mika, a provider of digital therapeutics (DTx) for all types of cancer, was selected as one of 16 members for the inaugural cohort of the 2024 CancerX Accelerator program supported by the White House.
Mika was chosen from more…
4 Min
More Show more items
